Article and Video CATEGORIES

Cancer Journey

Search By

Alexandra was born in El Salvador and has always had a very strong desire to do something that allows her to help others. She has worked in Digital Marketing since 2015, gaining experience working with different clients throughout Central America and the US.

She has been involved with cancer very closely in her family and knows that there’s never enough we can do to help cancer patients and families go through this difficult path.

2024 Ovarian Cancer Patient Education Program
Oncologists discuss emerging information and leading treatment techniques for patients with ovarian cancer.
Author
Alexandra Guandique-Beneke
Image
Ovarian Cancer 2024

In these videos, Dr. Mansoor Mirza discusses how endometrial cancer treatment has changed in the past decade, adjuvant radiotherapy for patients with early-stage disease, current phase III trials of adjuvant radiotherapy with chemo, and adjuvant chemo alone, the molecular profile of endometrial cancers and how it pertains to immunotherapy, immunotherapy options for treating advanced or recurrent endometrial cancer, study results from first-line endometrial cancer studies, and key takeaways to point out when discussing the changing field of endometrial cancer treatment.

To watch the complete playlist, click here. 

Transcripts.

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.